Clinically insignificant residual fragments after flexible ureterorenoscopy: Medium-term follow-up results

Urolithiasis

Volumn 42, Issue 6, 2014, Pages 533-538

  Ozgor, Faruk ^a   Simsek, Abdulmuttalip ^a   Binbay, Murat ^a   Akman, Tolga ^b   Kucuktopcu, Onur ^a   Sarilar, Omer ^a   Muslumanoglu, Ahmet Yaser ^b   Berberoglu, Yalcin ^a  

^a Haseki Research and Training Hospital ^*  (Turkey)

^b BEZMIALEM VAKIF UNIVERSITY   (Turkey)

Author keywords

CIRF; F URS; Stone recurrence; SWL; Urolithiasis

Indexed keywords

ADULT; ARTICLE; BIOCHEMISTRY; CLINICAL ARTICLE; CLINICAL EVALUATION; CLINICAL EXAMINATION; CLINICAL FEATURE; CLINICALLY INSIGNIFICANT RESIDUAL FRAGMENT; COMPUTER ASSISTED TOMOGRAPHY; EXTRACORPOREAL LITHOTRIPSY; FEMALE; FLEXIBLE URETEROSCOPE; FOLLOW UP; HUMAN; KIDNEY CLEARANCE; MALE; METABOLIC DISORDER; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RADIOLOGY; RECURRENCE RISK; SHOCK WAVE LITHOTRIPTER; STONE ANALYSIS; STONE FORMATION; TREATMENT OUTCOME; URETEROSCOPY; URINALYSIS; URINE CULTURE; UROLITHIASIS; KIDNEY CALCULI; MIDDLE AGED; PATHOLOGY; PREDICTIVE VALUE; RECURRENT DISEASE; RETROSPECTIVE STUDY; RISK FACTOR; URINE; ASYMPTOMATIC DISEASE; DISEASE SEVERITY; FIBERSCOPE ENDOSCOPY; FLEXIBLE URETERORENOSCOPY; NEPHROLITHIASIS; OUTCOME ASSESSMENT; PERCUTANEOUS NEPHROLITHOTOMY; PREOPERATIVE PERIOD; PROGNOSIS; URETER CATHETER;

ADULT; FEMALE; FOLLOW-UP STUDIES; HUMANS; KIDNEY CALCULI; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RECURRENCE; RETROSPECTIVE STUDIES; RISK FACTORS; URETEROSCOPY; URINALYSIS;

EID: 84927519311     PISSN: 21947228     EISSN: 21947236     Source Type: Journal    
DOI: 10.1007/s00240-014-0691-y     Document Type: Article

References (35)

1. Preminger GM, Assimos DG, Lingeman JE et al (2005) Chapter 1: AUA guideline on management of staghorn calculi: diagnosis and treatment recommendations. J Urol 173:1991-2000
2. Turk C, Knoll T, Petrik A et al (2010) Guidelines on Urolithiasis.: 1-106. Available at: www.uroweb.org/gls/pdf/Urolithiasis% 202010.pdf . Accessed 20 Jan 2012
3. Mirheydar HS, Palazzi KL, Derweesh IH et al (2013) Percutaneous nephrolithotomy use is increasing in the United States: an analysis of trends and complications. Endourol 27:979-983
4. Skolarikos A, de la Rosette J (2008) Prevention and treatment of complications following percutaneous nephrolithotomy. Curr Opin Urol 18:229-234
5. Hammad FT, Balakrishnan A (2010) The effect of fat and nonfat components of the skin-to-stone distance on shockwave lithotripsy outcome. J Endourol 24:1825-1829
6. Vella M, Caramia M, Maltese M et al (2007) ESWL prediction of outcome and failure prevention. Urol Int 79(Suppl 1):47-50
7. Aboumarzouk OM, Monga M, Kata SG et al (2012) Flexible ureteroscopy and laser lithotripsy for stones >2 cm: a systematic review and meta-analysis. J Endourol 26:1257-1263
8. Takazawa R, Kitayama S, Tsujii T (2012) Successful outcome of flexible ureteroscopy with holmium laser lithotripsy for renal stones 2 cm or greater. Int J Urol 19:264-267
9. Lingeman JE, Newman D, Mertz JH et al (1986) Extracorporeal shockwave lithotripsy: the Methodist Hospital of Indiana experience. J Urol 135:1134-1137
10. Beck EM, Riehle RA (1991) The fate of residual fragments after extracorporeal lithotripsy monotherapy for infection stones. J Urol 145:6-10
11. Fine JK, Pak CY, Preminger GM (1995) Effect of medical management and residual fragments on recurrent stone formation following shock wave lithotripsy. J Urol 153:27-32
12. Delvecchio FC, Preminger GM (2000) Management of residual stones. Urol Clin North Am 27:347-354
13. Acar C, Cal C (2012) Impact of residual fragments following endourological treatments in renal stones. Adv Urol. 2012:523-813
14. Streem SB, Yost A, Mascha E (1996) Clinical implications of clinically insignificant store fragments after extracorporeal shock wave lithotripsy. J Urol 155:1186-1190
15. Khaitan A, Gupta NP, Hemal AK et al (2002) Post-ESWL, clinically insignificant residual stones: reality or myth? Urology 59:20-24
16. Buchholz NP, Meier-Padel S, Rutishauser G (1997) Minor residual fragments after extracorporeal shockwave lithotripsy: spontaneous clearance or risk factor for recurrent stone formation? J Endourol 11:227-232
17. Raman JD, Bagrodia A, Gupta A et al (2009) Natural history of residual fragments following percutaneous nephrostolithotomy. J Urol 181:1163-1168
18. Denstedt JD, Clayman RV, Picus DD (1991) Comparison of endoscopic and radiologic residual fragments rate following percutaneous nephrolithotripsy. J Urol 145:703-705
19. Park J, Hong B, Park T et al (2007) Effectiveness of noncontrast computed tomography in evaluation of residual stones after percutaneous nephrolithotomy. J Endourol 21:684-687
20. Weizer AZ, Auge BK, Silverstein AD et al (2002) Routine postoperative imaging is important after ureteroscopic Stone manipulation. J Urol 168:46-50
21. Halachmi S, Ghersin E, Ginesin Y et al (2007) Antegrade pyelography versus unenhanced multidetector CT in the assessment of urinary-tract stones after percutaneous nephrostomy insertion: a prospective blinded study. J Endourol 21:473-477
22. Somani BK, Desai M, Traxer O, Lahme S (2014) Stone-free rate (SFR): a new proposal for defining levels of SFR. Urolithiasis 42:95
23. Zanetti G, Montanari E, Mandressi A et al (1991) Long-term results of extracorporeal shockwave lithotripsy in renal stone treatment. J Endourol 5:61-64
24. Candau C, Saussine C, Lang H et al (2000) Natural history of residual renal stone fragments after ESWL. Eur Urol 37:18-22
25. Drach GW, Dretler S, Fair W et al (1986) Reports of the United States cooperative study of extracorporeal shock wave lithotripsy. J Urol 135:1127-1133
26. Psihramis KE, Jewett MA, Bombardier C et al (1992) Lithostar extracorporeal shock wave lithotripsy: the first 1,000 patients. Toronto Lithotripsy Associates. J Urol 147:1006-1009
27. Moon YT, Kim SC (1993) Fate of clinically insignificant residual fragments after extracorporeal shock wave lithotripsy with EDAP LT-01 lithotripter. J Endourol 7:453-456
28. Yuruk E, Tefekli A, Sari E et al (2009) Does previous extracorporeal shock wave lithotripsy affect the performance and outcome of percutaneous nephrolithotomy? J Urol 181:663-667
29. Ettinger B, Pak CYC, Citron JT et al (1997) Potassium-magnesium citrate is an effective prophylaxis against recurrent calcium oxalate nephrolithiasis. J Urol 158:2069-2073
30. Whalley NA, Meyers AM, Martins M et al (1996) Long term effects of potassium citrate therapy on the formation of new Stones in groups of recurrent stone formers with hypocitraturia. Br J Urol 78:10-14
31. Altunrende F, Tefekli A, Stein RJ et al (2011) Clinically insignificant residual fragments after percutaneous nephrolithotomy: medium-term follow-up. J Endourol 25:941-945
32. Sarica K, Erturhan S, Yurtseven C et al (2006) Effect of potassium citrate therapy on stone recurrence and regrowthafter extracorporeal shockwave lithotripsy in children. J Endourol 20:875-879
33. Fine KF, Pak CYC, Perminger GM (1995) Effects of medical management and residual fragments on recurrent stone formation following shock wave lithotripsy. J Urol 153:27-33
34. Soygür T, Akbay A, Küpeli S (2002) Effect of potassium citrate therapy on stone recurrence and residual fragments after shockwave lithotripsy in lower caliceal calcium oxalate urolithiasis: a randomized controlled trial. J Endourol 16:149-152
35. Cicerello E, Merlo F, Gambaro G et al (1994) Effect of alkaline citrate therapy on clearance of residual renal stone fragments after extracorporeal shock wave lithotripsy in sterile calcium and infection nephrolithiasis patients. J Urol 151:5-9